Aignostics and the Pancreatic Cancer Action Network (PanCAN) entered an alliance to apply Aignostics’ Atlas H&E tumor microenvironment software to spatially profile pancreatic cancer pathology slides from PanCAN. The collaboration focuses on leveraging H&E-based computational analyses to derive spatial insights in tissue images. By using PanCAN’s resources, the partners aim to support translational research into tumor microenvironment biology in pancreatic cancer, with Atlas H&E used as the core software platform for spatial profiling. The report did not disclose financial terms. For biotech researchers, the agreement reflects ongoing adoption of spatial pathology informatics as a bridge between biomarker discovery and therapeutic target rationales, especially in cancers where clinical outcomes depend heavily on microenvironmental context.